Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C. (Q50570727)
Jump to navigation
Jump to search
scientific article published on 20 August 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C. |
scientific article published on 20 August 2007 |
Statements
Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C. (English)
1 reference
Hiromitsu Kumada
1 reference
Naoki Hiramatsu
1 reference
Nao Kurashige
1 reference
Tsugiko Oze
1 reference
Tetsuo Takehara
1 reference
Shinji Tamura
1 reference
Akinori Kasahara
1 reference
Masahide Oshita
1 reference
Kazuhiro Katayama
1 reference
Harumasa Yoshihara
1 reference
Yasuharu Imai
1 reference
Michio Kato
1 reference
Sumio Kawata
1 reference
Hirohito Tsubouchi
1 reference
Takeshi Okanoue
1 reference
Shinichi Kakumu
1 reference
Norio Hayashi
1 reference
20 August 2007
1 reference
38
1 reference
1
1 reference
52-59
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference